Literature DB >> 8269325

Cardiac arrhythmias in Chagas' heart disease.

M V Elizari1, P A Chiale.   

Abstract

Chagas' disease is a chronic parasitosis affecting most Latin American countries. Its most important clinical manifestation is a late developing chronic myocarditis and, much less frequently, an early acute myocarditis. Chagasic myocardial damage is microfocal and disseminated throughout the heart. In most cases, the coexistence of areas of myocytic degeneration, inflammatory infiltration, and fibrosis suggests a permanent evolving process. Commonly, chronic chagasic myocarditis resembles a dilated cardiomyopathy, with characteristic ECG abnormalities (atrial and ventricular extrasystoles, intraventricular and/or AV conduction disturbances, and primary ST-T wave changes). Since myocardial damage is scattered throughout the heart, the ECG abnormalities (arrhythmias, conduction disturbances, and repolarization changes) are also representative of the widespread cardiac involvement. Thus, sick sinus syndrome, atrial extrasystoles, intraatrial conduction disturbances, and atrial fibrillation or flutter are common findings in different stages of the disease. At the ventricular level, both conduction disturbances and arrhythmias are conspicuous expressions of the myocardial damage. Right bundle branch block alone or in combination with left anterior hemiblock are the most common conduction defects. Further compromise of the conduction system can lead to different degrees of AV block. Chagas' disease is the main cause of bundle branch block and AV block in endemic areas. In advanced cases of Chagas' heart disease, ventricular premature contractions are extremely frequent, multiform, and repetitive (couplets and runs of ventricular tachycardia), and show R on T phenomenon. These arrhythmias are usually aggravated by increased sympathetic tone, implying an enhanced risk of cardiac sudden death among chagasic patients, which is sometimes the first manifestation of the illness. Chronic chagasic myocarditis is the leading cause of cardiovascular death, mostly as a consequence of heart failure and sudden death, in areas where the disease is endemic.

Entities:  

Mesh:

Year:  1993        PMID: 8269325     DOI: 10.1111/j.1540-8167.1993.tb01247.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  20 in total

1.  Exercise stress testing as a predictor of progression of early chronic Chagas heart disease.

Authors:  R Viotti; C Vigliano; B Lococo; M Petti; G Bertocchi; F De Cecco; M G Alvarez; S Laucella; A Armenti
Journal:  Heart       Date:  2006-03       Impact factor: 5.994

2.  Generation and escape of local waves from the boundary of uncoupled cardiac tissue.

Authors:  Vadim N Biktashev; Ara Arutunyan; Narine A Sarvazyan
Journal:  Biophys J       Date:  2008-01-22       Impact factor: 4.033

Review 3.  The emerging role of amiodarone and dronedarone in Chagas disease.

Authors:  Gustavo Benaim; Alberto E Paniz Mondolfi
Journal:  Nat Rev Cardiol       Date:  2012-08-07       Impact factor: 32.419

4.  Ventricular arrhythmias in chronic Chagas cardiomyopathy: Can studying myocardial sympathetic denervation provide the answers?

Authors:  Vineet Kumar
Journal:  J Nucl Cardiol       Date:  2016-07-12       Impact factor: 5.952

5.  Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries.

Authors:  Joana Cortez; Rui Providência; Evelise Ramos; Cristina Valente; Jorge Seixas; Manuela Meruje; António Leitão-Marques; António Vieira
Journal:  World J Cardiol       Date:  2012-07-26

6.  Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease.

Authors:  E Mahler; J Hoebeke; M J Levin
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

7.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  Trypanosoma cruzi Neurotrophic Factor Facilitates Cardiac Repair in a Mouse Model of Chronic Chagas Disease.

Authors:  Tamar Ledoux; Daniel Aridgides; Ryan Salvador; Njabulo Ngwenyama; Smaro Panagiotidou; Pilar Alcaide; Robert M Blanton; Mercio A Perrin
Journal:  J Pharmacol Exp Ther       Date:  2018-10-22       Impact factor: 4.030

Review 9.  New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT.

Authors:  André d'Avila; Robert Splinter; Robert H Svenson; Mauricio Scanavacca; Ernest Pruitt; Jackie Kasell; Eduardo Sosa
Journal:  J Interv Card Electrophysiol       Date:  2002-08       Impact factor: 1.900

10.  Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

Authors:  V Labovsky; C R Smulski; K Gómez; G Levy; M J Levin
Journal:  Clin Exp Immunol       Date:  2007-04-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.